Quest Diagnostics Nichols Institute

What Quest Diagnostics Nichols Institute does

Quest Diagnostics Nichols Institute is the specialty laboratory division of Quest Diagnostics Incorporated (NYSE: DGX), originally founded in 1971 (with the broader Quest franchise tracing to 1967) and headquartered in Chantilly, Virginia, operating as Quest's center of excellence for advanced and esoteric diagnostic testing. Its core offering is clinical laboratory testing across 30+ specialty areas, including oncology, genetics, neurology, cardiovascular, and infectious diseases, anchored by CLIA-certified, HIPAA-covered operations and supported by 650+ medical, scientific, and regulatory thought leaders. The technology stack is built around two interconnected platforms: MyQuest, a patient-facing portal for results, scheduling, and health history tracking, and the Quanum suite for providers (Lab Services Manager, eLabs for EHR-integrated ordering and ePrescribing, Clinical Insights Companion for longitudinal trend and care-gap analysis, and IntelliTest Manager analytics), with mobile access via Quest Mobile and consumer-direct purchasing via questhealth.com.

The company monetizes across three principal revenue streams: clinical laboratory testing services billed to patients, insurers, Medicare, and Medicaid; enterprise/B2B services including population health management, employer wellness and drug screening, and health plan lab spend optimization; and life sciences services spanning biomarker education, clinical trial lab services, and commercialization support for pharma, biotech, CROs, and MedTech. Its go-to-market is a hybrid motion combining direct-to-consumer e-commerce (questhealth.com with 150+ tests available without a doctor's visit), enterprise field sales to hospitals, health systems, employers, and health plans, and a specialized sales-led motion for life sciences. Specialized assay content — including QUEST AD-Detect Amyloid Beta 42/40 for Alzheimer's treatment candidacy and the ELF Score for NAFLD/NASH risk — anchors the high-value specialty franchise. The company has not disclosed segment-level revenue, leadership details, M&A activity, or funding rounds in the data set.

Name

Quest Diagnostics Nichols Institute

Legal name

Quest Diagnostics Incorporated

Website

https://nicholsinstitute.com

Company type

Public

Founded year

1967

Operating status

Operating

Headcount range

1–10 employees

Short description

Quest Diagnostics Nichols Institute is the specialty laboratory division of Quest Diagnostics (NYSE: DGX), providing advanced diagnostic testing across oncology, genetics, neurology, cardiovascular, and infectious diseases for hospitals, employers, health plans, life sciences firms, and patients.

Ownership category

akta.pro rank

Product category

Clinical Laboratory Testing Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Reference & Esoteric Testing Laboratories (HLAFAMAJ)

akta.pro secondary industries

Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI), Bioanalytical Testing (PK/ADA/NAb) (HLAGADAA), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Point-of-Care & Decentralized Trial Testing Services (HLAGAEAK)

Keywords

• Clinical laboratory testing
• Diagnostic testing services
• Specialty lab services
• Biomarker diagnostic tests
• Patient lab portals

Headquarters

HQ city

San Juan Capistrano

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Clinical Laboratory Testing Services: Diagnostic testing services billed to patients, insurance companies, Medicare/Medicaid, and healthcare providers. Revenue generated through specimen collection and laboratory analysis acrossQuest Diagnostics patient service centers and healthcare facility networks.
2. Enterprise/B2B Lab Services: Population health management, employer wellness screening, health plan lab spend optimization, and hospital collaborative lab solutions for enterprise customers.
3. Life Sciences Services: Clinical trial lab services, biomarker education, sponsored testing for pharma, biotech, and medical device companies.

Pricing tiers

Go-to-market motion3 records

Distribution channels6 records

Marketing channels5 records

Core offering

Quest Diagnostics Nichols Institute provides advanced clinical laboratory testing services through CLIA-certified specialty laboratories, covering oncology, genetics, neurology, cardiovascular, and infectious disease specialties. Offerings include direct-to-consumer lab tests, healthcare provider-ordered diagnostic testing with digital ordering and results via the Quanum platform, employer and health-plan population health programs, and clinical trial lab services for life sciences customers.

Product overview

Quest Diagnostics Nichols Institute operates a platform-plus-modules architecture offering diagnostic laboratory testing services. The core patient-facing offering is MyQuest®, a portal for accessing test results and scheduling appointments. For healthcare professionals, the Quanum® platform provides lab services management including Quanum Lab Services Manager, Quanum eLabs (EHR integration and ePrescribing), and Clinical Insights Companion. The company offers direct-to-consumer testing through Quest Health (150+ tests without a doctor's visit) and Quest Mobile™ for at-location sample collection. Specialized diagnostic tests include QUEST AD-Detect Amyloid Beta 42/40 for Alzheimer's risk and the ELF™ Score for liver disease (NAFLD/NASH). COVID-19 molecular, antigen, and antibody testing services are also available.

Differentiator

Problem solved

Functional benefit

Brands

• Nichols Institute: Specialty laboratory focused on advanced diagnostic testing, serving as Quest Diagnostics' center of excellence for specialized tests.

Products and services

• MyQuest® Patient Portal Free online portal that lets patients view test results, book or reschedule lab appointments, access family results, and manage personal health history.
• Quanum® Lab Services Manager Online business tool for healthcare providers to order lab tests, view patient results, order supplies, and access Lab Utilization Reports with real-time Priority and STAT result notifications.
• Clinical Insights Companion Longitudinal analytics tool that consolidates a patient's lab history from multiple sources, surfaces trends across time and conditions, and identifies care gaps and emerging clinical patterns for providers.
• Quest Health Direct-to-Consumer Lab Testing Direct-to-consumer e-commerce platform offering 150+ lab tests that individuals can purchase without a doctor's visit, with results delivered through MyQuest.
• Quest Mobile™ Mobile Phlebotomy Service Mobile phlebotomy service that dispatches a phlebotomist to a patient's home or chosen location for specimen collection.
• QUEST AD-Detect Amyloid Beta 42/40 Blood-based biomarker assay intended to help identify patients who may be candidates for early antibody treatment for Alzheimer's disease.
• ELF™ Score Specialty diagnostic test for identifying patients at risk for nonalcoholic fatty liver disease (NAFLD) and NASH.
• COVID-19 Testing Services SARS-CoV-2 laboratory testing services including molecular PCR, rapid antigen, and antibody blood tests for individual and workforce screening.
• Life Sciences Clinical Trial Lab Services Enterprise service for pharma, biotech, CRO, MedTech, and academic customers covering discovery, clinical-trial laboratory support, biomarker education, sponsored testing, and commercialization launch assistance.

Quantifiable outcome

• Millions of SARS-CoV-2 tests processed for workforce screening
• +2 more outcomes

Named customers3 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• Academic HospitalscoreStrategic or Co-development PartnerCollaborations with academic hospitals on medical and scientific research including diagnostic excellence, biomarker education, and population health management. The 650+ medical, scientific, and regulatory thought leaders support academic collaboration in discovery, clinical trials, and commercialization.
• Community Health CenterscoreStrategic or Co-development PartnerPartnership to improve community engagement and health by providing access to efficient, high-quality, comprehensive health care regardless of financial, geographic, or social barriers.
• Accountable Care Organizations (ACOs)coreStrategic or Co-development PartnerCollaborative relationship to achieve better care for patients and better population health through delivery of high-quality, integrated, affordable health care and sustainable change in quality and outcomes.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• ARUP Laboratories: ARUP is a nonprofit reference laboratory specializing in esoteric testing across pathology, genetics, and infectious disease, serving academic hospitals and health systems — directly comparable to Nichols Institute's specialty/reference lab role within Quest.
• Laboratory Corporation of America (Labcorp): Labcorp is Quest's closest direct competitor, offering a comparable U.S. clinical laboratory testing menu across routine, esoteric, and DTC channels (including Labcorp OnDemand) with similar B2B outreach to hospitals and health systems.
• Mayo Clinic Laboratories: Mayo Clinic Laboratories is an academic reference lab offering a deep esoteric test menu and serving hospitals, health systems, and life sciences clients globally, overlapping directly with Quest's specialty testing and clinical trial lab services.
• BioReference Laboratories: BioReference (an OPKO Health company) offers clinical diagnostics with a strong focus on specialty/esoteric testing, women's health, and oncology — directly comparable to Quest's niche specialty testing portfolio.

Broad incumbents

• Eurofins Scientific: Eurofins is a global leader in bioanalytical and clinical laboratory testing for pharma, food, and clinical diagnostics, overlapping with Quest's life sciences and specialty testing services at a broader scale.
• ICON plc: ICON is a leading global CRO providing central lab and clinical trial lab services to pharma and biotech, directly comparable to Quest's life sciences clinical trial lab offerings.
• Sonic Healthcare: Sonic Healthcare is a global medical diagnostics provider operating clinical labs, radiology, and pathology services across multiple geographies, with overlapping specialty testing and reference lab capabilities relative to Quest.

Emerging players

• Natera: Natera is a specialty genetics testing company in oncology, reproductive health, and organ transplant monitoring, competing with Quest's molecular and specialty genetic testing services.
• Guardant Health: Guardant is a specialty oncology liquid biopsy and genomics company focused on advanced cancer testing, competing with Quest's oncology and genetic specialty testing on the high end of the market.

Others

• Syneos Health (clinical lab services): Syneos is a CRO/biopharma services organization with clinical research lab partnerships that overlap thematically with Quest's life sciences clinical trial lab support business.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xquestdiagnostics.com/social-media
• YouTubeyoutube.com/questdiagnostics
• Facebookfacebook.com/questdiagnostics
• LinkedInlinkedin.com/company/quest-diagnostics-nichols-institute
• Instagraminstagram.com/questdiagnostics

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Quest Diagnostics Nichols Institute